Nehal Modha, DPM
Foot & Ankle Surgery · McKinney, TXNPI 1508495714
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Stryker at 58.6% of the total. Reporting peaked in 2024 at $1,953 and has fallen 58.6% since, to $809 in 2025.
Across 51 payments — averaging $113.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Biotissue Holdings Inc.$604
- Voom Medical Devices, Inc.$521
- Amgen$231
- Amniox Medical, Inc.$170
- Fusion Orthopedics USA, LLC$150
- plus $713 from 7 others
What the payments were for
- Travel & lodging$1,53227%
- Food & beverage$3,14955%
- Education$1,08519%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 29 | $3,378 |
| Biotissue Holdings Inc. | 8 | $604 |
| Voom Medical Devices, Inc. | 2 | $521 |
| Amgen | 2 | $231 |
| Amniox Medical, Inc. | 2 | $170 |
| Fusion Orthopedics USA, LLC | 1 | $150 |
| Bone Support Inc. | 1 | $148 |
| Zimmer Biomet | 1 | $138 |
| Heron Therapeutics, Inc. | 1 | $125 |
| Nevro Corp. | 1 | $122 |
| Organogenesis Inc. | 1 | $86 |
| Smith+Nephew | 1 | $74 |
| Paragon 28, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CITREFIX$1,085
- AUGMENT INJECTABLE$807
- AXSOS$807
- VARIAX$807
- HOFFMANN$807
- GAMMA$807
- REVCON INSTRUMENT KIT, STERILE$521
- PROPHECY$387
- KRYSTEXXA$231
- CERAMENTBONE VOID FILLER$148
- CERAMENT G$148
- Stratum Foot Plating System$138
- Zynrelef$125
- Omnia$122
- SALVATION$119
- N/A$114
- PROSTEP MICA$110
How this compares
$5,766 in reported general payments places this provider in the 60th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in McKinney
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Mark DaltonAustin$1.9M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
- Sherman NaglerHouston$602K
- John EarlyDallas$553K
- Michael DowneySouthlake$475K
- Abdul NurudeenHouston$404K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.